Athanor Capital, LP Kymera Therapeutics, Inc. Transaction History

Athanor Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$31.08 - $51.95 $199,191 - $332,947	-6,409 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$35.64 - $85.46 $466,278 - $1.12 Million	-13,083 Reduced 67.12%	6,409 $249,000
Q4 2020 Feb 16, 2021	BUY	$28.07 - $87.83 $276,545 - $865,301	9,852 Added 102.2%	19,492 $1.21 Million
Q3 2020 Nov 16, 2020	BUY	$26.1 - $33.28 $251,604 - $320,819	9,640 New	9,640 $311,000

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.46B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.